Sleep-disordered breathing is more common in hypertensive disorders during pregnancy; however, most studies have not adequately accounted for the potential confounding impact of obesity. This study evaluated the frequency of sleep-disordered breathing in women with gestational hypertension and pre-eclampsia compared with body mass index-and gestation-matched normotensive pregnant women. Women diagnosed with gestational hypertension or pre-eclampsia underwent polysomnography shortly after diagnosis. Normotensive controls body mass index-matched within AE4 kg m À2 underwent polysomnography within AE4 weeks of gestational age of their matched case. The mean body mass index and gestational age at polysomnography were successfully matched for 40 women with gestational hypertension/preeclampsia and 40 controls. The frequency of sleep-disordered breathing in the cases was 52.5% compared with 37.5% in the control group (P = 0.18), and the respiratory disturbance index overall did not differ (P = 0.20). However, more severe sleep-disordered breathing was more than twice as common in women with gestational hypertension or preeclampsia (35% versus 15%, P = 0.039). While more than half of women with a hypertensive disorder of pregnancy meet the clinical criteria for sleep-disordered breathing, it is also very common in normotensive women of similar body mass index. This underscores the importance of adjusting for obesity when exploring the relationship between sleepdisordered breathing and hypertension in pregnancy. More severe degrees of sleep-disordered breathing are significantly associated with gestational hypertension and pre-eclampsia, and sleep-disordered breathing may plausibly play a role in the pathophysiology of pregnancy hypertension in these women. This suggests that more severe sleepdisordered breathing is a potential therapeutic target for reducing the prevalence or severity of hypertensive disorders in pregnancy.
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IN TROD UCTI ON
Hypertensive disorders of pregnancy (HDP) are the most common and serious medical disorders in pregnancy, affecting 3-8% of pregnant women, and responsible for over 60 000 maternal deaths and far greater numbers of perinatal deaths worldwide every year (Redman and Sargent, 2005; Sibai et al., 2005) . Gestational hypertension (GH) is characterised by the new onset of hypertension after 20 weeks gestation, whereas pre-eclampsia (PE) is diagnosed when GH is accompanied by multisystem organ dysfunction (Tranquilli et al., 2014) ; most typically renal involvement manifesting as proteinuria. Once established, PE inexorably worsens until delivery. PE can have a range of life-threatening complications, including maternal liver damage, renal failure and seizures, with increased risks of pre-term birth and foetal growth restriction (Sibai et al., 2005) . There is no cure, and the mainstay of management is delivery of the foetus. Although GH alone is generally associated with a good prognosis, up to a quarter of women with GH will go on to develop PE and therefore close surveillance is required (Lowe et al., 2015) . Because of the disease burden associated with HDP, contributors that have an effective treatment could have an important impact on the health of women and their offspring.
In the non-pregnant population, sleep-disordered breathing (SDB) confers a threefold increase in risk of hypertension independent of other risk factors (Chen and He, 2007) . Perimenopausal women with SDB have a higher prevalence of hypertension and antihypertensive medication use (Pedrosa et al., 2014) , while snoring and symptoms of SDB are commonly reported during pregnancy (Franklin et al., 2000) . SDB during pregnancy appears to be linked to adverse outcomes for the mother and baby (Bourjeily et al., 2011; Fung et al., 2012) and, in particular, was significantly associated with GH and PE in a recent large prospective cohort study (Facco et al., 2017) . On the other hand, obesity is a risk factor for both increased blood pressure during pregnancy and PE (Gaillard et al., 2011) , it is also a wellrecognised risk factor for SDB (Young et al., 2005) and a determinant of developing SDB in pregnancy (Pien et al., 2014) . Thus, the relative contribution of SDB and obesity to HDP requires independent evaluation.
Several cross-sectional studies have identified an increased frequency of objectively-measured SDB in HDP, but many have not adjusted for the confounding effect of obesity. For example, Reid et al. (2011) demonstrated that women with GH with or without proteinuria were at least four times more likely to have SDB compared with women with uncomplicated pregnancies. However, the women with GH had a substantially higher body mass index (BMI) on average (37.4 kg m À2 versus 28.7 kg m À2 , P = 0.0001). Other studies have statistically accounted for BMI in multivariate tests (Champagne et al., 2009; Facco et al., 2017) , but no studies to date have used a BMI-matched approach to assess the impact of HDP on SDB prevalence. This study aims to address this gap in the literature, by exploring the relationship between HDP and SDB [assessed with full polysomnography (PSG)], using a closely matched design to control for the effect of obesity. We hypothesised that pregnant women with HDP (both GH and PE) will have a higher rate of SDB compared with BMI-and gestationmatched normotensive pregnant women.
MATERI ALS AND METHODS

Study participants
This was a single-centre, cross-sectional study conducted between October 2012 and October 2015, comparing the prevalence of SDB in late pregnancy among women with HDP to women with uncomplicated pregnancies. The Human Research Ethics Committees at Austin Health, Mercy Hospital for Women and University of Melbourne approved the study, and written informed consent was obtained from all participants.
Cases included women with a singleton pregnancy diagnosed with GH or PE not requiring immediate delivery between 26 and 37 weeks gestation, and were recruited from the Pregnancy Day Assessment Centre or were inpatients at Mercy Hospital for Women. Hypertension in pregnancy was defined as systolic blood pressure greater than or equal to 140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg, confirmed by a minimum of two readings over several hours. GH was defined as the new onset of hypertension after 20 weeks of gestation (Tranquilli et al., 2014) . We used the most recent International Society for the Study of Hypertension in Pregnancy (ISSHP) definition of PE: new hypertension after 20 weeks gestation and one or more of the following new-onset conditions: (i) proteinuria; (ii) other maternal organ dysfunction (renal insufficiency, liver involvement or neurological complications); and (iii) uteroplacental dysfunction -foetal growth restriction (Tranquilli et al., 2014) . Women with chronic hypertension who developed superimposed PE (diagnosed when one or more systemic features of PE occur after 20 weeks gestation in addition to pre-existing hypertension) were also considered eligible cases.
Control participants were normotensive pregnant women one-to-one matched by BMI (within AE4 kg m
À2
, measured at the first antenatal appointment) to each of the cases, and were recruited from the antenatal outpatient clinic. Control participants had otherwise uncomplicated pregnancies and were confirmed to have an appropriately grown foetus (estimated foetal weight >10th centile with normal foetoplacental Doppler studies) prior to inclusion. All potentially eligible women were screened by medical record review. Exclusion criteria included <18 years of age, multiple gestation, foetal abnormality or other maternal/foetal condition likely to mandate early or imminent delivery, and previous diagnosis of a sleep disorder.
Investigational measures
PSG
Attended overnight PSG was conducted in the Austin Health sleep laboratory using the Compumedics E series (Abbotsford, Victoria, Australia), or unattended in the participant's home with the Somt e (Compumedics) portable sleepmonitoring device. Participants who were inpatients were also studied using the portable device. Signals recorded both in-laboratory and portably included electroencephalogram (EEG; with recommended derivations of F4, C4 and O2 referenced to M1), electrooculogram, electromyogram, electrocardiogram, arterial oxygen saturation, thoracic and abdominal respiratory effort via inductance plethysmography, nasal airflow measured via nasal cannula, oronasal thermistor, leg movements, snoring and body position. Recordings ª 2018 European Sleep Research Society were sleep-staged and respiratory-scored by a single experienced sleep technologist who was blinded to maternal hypertensive status. As per the AASM criteria (Berry et al., 2016) , respiratory events were categorised as apneas, hypopneas, and respiratory event-related arousals (RERAs). The number of apneas and/or hypopneas per hour of sleep was calculated as the apnea/hypopnea index (AHI). The addition of RERAs per hour to the AHI was expressed as the respiratory disturbance index (RDI). The oxygen desaturation index (ODI ≥ 3%) was defined as the number of arterial oxygen desaturations of ≥3% from baseline, per hour of sleep (Berry et al., 2016) .
All participants diagnosed with SDB at an RDI ≥ 5 were offered clinical follow-up with a sleep physician, whereas those diagnosed at an RDI ≥ 15 or with clinically significant symptoms (i.e. falling asleep while driving) were given urgent follow-up within 2 weeks of the PSG.
SDB questionnaire
The Berlin Questionnaire (Netzer et al., 1999) assesses pretest probability of obstructive sleep apnea (OSA). Predetermination of high risk and low risk for OSA was based on responses in three symptom-based categories -snoring, daytime sleepiness, and high blood pressure and/or BMI.
Procedures
After consent was obtained, participants with GH and PE underwent overnight PSG at their earliest convenience. Each control participant underwent PSG within AE4 weeks of gestational age of their matched case. At the time of the PSG, the Berlin Questionnaire was completed, and height and weight were recorded. Neck circumference was measured at the most prominent part of the thyroid cartilage while the participant was standing. A sleep technologist with over 10 years of experience (DW) was responsible for all sleep monitoring and anthropometric measurements.
Statistical analysis
All statistical analyses were performed with SPSS 21.0 (SPSS, Chicago, IL, USA). Values are given in means with standard deviations (M AE SD) or median and interquartile range [Mdn (IQR)] for non-normally distributed variables. A two-sided P-value of less than 0.05 was considered to indicate statistical significance. SDB as the primary outcome was defined as an RDI of ≥5 events per hour. Secondary outcomes included diagnosis of SDB using stricter cut-offs of RDI ≥10, ≥15 and ≥30, and median RDI.
To test the hypothesis that SDB was more common in women with HDP, the proportions of those with an RDI ≥5, 10, 15 and 30 were compared with the control group using the chi-square test. Within-subjects analysis for SDB and sleep variables was conducted using paired-sample t-tests for normally-distributed continuous variables and Wilcoxon signed-rank tests for non-normally distributed continuous variables. Cross-tabulations were done to determine sensitivity and specificity values for the Berlin Questionnaire.
Sample size was based on the previously reported prevalence of SDB (RDI ≥ 5) in GH disorders being 53% (Reid et al., 2011) compared with 19.7% in a clinical obstetric population (Pien et al., 2014) . A sample size of 64 (32 cases and 32 controls) would be required to provide a power of 80% (alpha = 0.05) to detect this increased prevalence of SDB in HDP. As obesity is a risk factor for both PE and SDB, we suspected that the matched controls would likely be heavier and have a higher prevalence of SDB than previously reported, hence a decision was made to increase the sample size by 25% (40 cases and 40 controls).
RESULTS
A total of 81 pregnant women participated (see Consort Diagram, Fig. 1 ), with one home sleep study failure in the control group due to signal loss. An in-laboratory sleep study was chosen by 22 participants and a home sleep study chosen by 58. The severity of SDB was not different between these two groups (P = 0.45); the only difference in overall sleep quality was better sleep efficiency for those who slept at home (81.7 AE 9.8%) compared with the laboratory (76.0 AE 10.7%, P = 0.03). Table 1 confirms the hypertensive and control groups were carefully matched for age, BMI and gestational age at the time of the sleep study. The average age was 32.9 AE 4.6 years, and BMI values at the first antenatal appointment and at the time of the sleep study were 32.6 AE 7.1 kg m À2 and 36.3 AE 6.6 kg m À2 respectively, with no differences between cases and controls. Neck circumference was significantly larger for the HDP women compared with their BMI-matched controls. Sleep studies in both groups were performed at approximately 33 weeks gestation. At the time of the sleep study, 23 (58%) of the hypertensive participants were taking anti-hypertensive medication, most commonly Labetalol, Aldomet, or a combination of the two.
Prevalence of SDB
Using our a priori definition of RDI ≥ 5, 36/80 (45%) women in the study met the diagnostic criteria for SDB. SDB was more commonly observed among women with HDP (53%) than the control group (38%), but this difference was not statistically significant (Table 2 ). An RDI ≥ 10 was significantly more common among women with HDP (35% compared with 15%, P = 0.04). A similar trend was seen for moderate SDB (RDI ≥ 15) and severe SDB (RDI ≥ 30), but due to small numbers these associations failed to achieve statistical significance (Table 2 ). There were no differences in the prevalence of SDB according to the severity of hypertensive disease (Fig. 2) . The median RDI and AHI did not differ between the HDP and control group overall (Table 3) ; however, the HDP group had a significantly higher RDI during non-rapid eye movement (NREM) sleep and supine sleep (Fig. 3 ). There were trends toward a higher ODI ≥ 3% and a lower SpO 2 nadir in the HDP group, but these were not statistically significant.
Sleep quality was comparable across the HDP group and their matched controls, apart from a lower percentage of rapid eye movement (REM) sleep in the HDP group (Table 4) .
Within our cohort, neck circumference was a significant predictor of HDP [odds ratio (OR) 1.58, 95% confidence interval (CI) 1.20-2.08]; however, the trend towards more commonly observed SDB in the HDP group could not be explained by a relationship between neck circumference and RDI (r s = 0.12, P = 0.33). RDI was weakly related to BMI at the sleep study (r s = 0.26, P = 0.03); those with an RDI ≥ 5 had a higher BMI than those without SDB in the HDP group (38.4 AE 6.4 kg m À2 versus 33.8 AE 7.0 kg m À2 , P = 0.04), with a similar trend observed in the control group (38.5 AE 6.7 kg m À2 versus 35.1 AE 5.5 kg m
À2
, P = 0.09).
Self-report data
The majority of women in both the hypertensive and control groups were considered at high risk of SDB (Table 5) . Significantly more women in the HDP group reported snoring at least 3 nights per week compared with their matched 
DISCUSSION
Previous research has suggested a relationship between HDP and SDB; however, this study is the first to prospectively address the potential confounding role of obesity using BMI-matching and gold-standard PSG to assess SDB. We found SDB to be more common in our control group than in previous studies (O'Brien et al., 2014; Reid et al., 2011) , confirming that BMI is an important co-variate that requires evaluation in future studies exploring the relationship between SDB and HDP. While SDB occurred in more than half of women with HDP, over a third of BMI-matched controls also had SDB. We found no increase in the overall median RDI and AHI in the HDP group compared with BMImatched controls. In a planned secondary analysis, we report a significant independent association between HDP and moderate SDB, suggesting that SDB may still play an important role in the development of hypertension in pregnancy.
That the relationship between HDP and SDB is partly confounded by the presence of obesity is unsurprising, as obesity is a known risk factor for both. SDB may be a mechanism by which obesity and adverse perinatal outcomes are linked, but given the important contribution of obesity to both SDB and HDP, failing to adjust for this co-variate will overestimate the strength of association between SDB and HDP. A dose-response relationship has been described for both GH and PE among women with Class 1, 2 and 3 obesity (Trojner Bregar et al., 2017) and, in a large Danish population cohort of nearly 71 000 women, the risk of PE increased linearly with BMI among nulliparous women (Catov et al., 2007) . Obesity drivers of HDP include increased sympathetic activation, inflammation and oxidative stress. These contribute to placental ischaemia, which in turn leads to placental production and release of anti-angiogenic factors, such as soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble-endoglin (sEng). These circulating factors cause widespread endothelial dysfunction, with the resultant multisystem damage seen in PE (Powe et al., 2011) . Obesity is also a strong risk factor for SDB in the non-pregnant (Young al., 2005) and pregnant population (Facco et al., 2017) and, in particular, BMI, neck girth and central fat patterning may independently contribute to SDB (Young et al., 2002) . Excess body weight may affect breathing in numerous ways, including changes in upper airway structure or function, reduced chest wall compliance, and alterations in the balance between ventilatory drive and load (Strobel and Rosen, 1996) . Interestingly, within our sample we had six women with a BMI of about 50 kg m À2 , but only two of these women had SDB (one with GH/PE and one control). There are clearly reasons other than obesity (such as changes in hormone levels, respiratory function, and the upper airway and nasal mucosa) that determine whether SDB will be present during pregnancy. Protective factors, such as increased progesterone stimulating ventilatory drive and increasing responsiveness of the upper airway dilator muscle (Popovic and White, 1998) , may explain why some women with such a high BMI escape SDB. Consistent with the observations of others (Champagne et al., 2009; Facco et al., 2017) , we confirm a significant association of moderate-severe SDB and HDP. In particular, we found similar frequencies of SDB in HDP across RDI categories to both Reid et al. (2011) and Facco et al. (2013) , and like Reid et al. (2011) we found no differences in SDB frequency between GH and PE. We found a doubling of prevalence for the GH/PE group compared with the control group at the level of RDI ≥10 and RDI ≥30, implying that more severe levels of SDB may contribute to the development of HDP. SDB and PE share similar biological pathways. The recurrent episodes of hypoxia in SDB are known to result in sympathetic activation, oxidative stress and activation of inflammatory pathways that can lead to endothelial dysfunction (Somers and Javaheri, 2011) ; a weak negative trend between SDB severity and endothelial function in PE women has been described by Yinon et al. (2006) . These are the proposed mechanisms by which SDB results in hypertension and may plausibly contribute to the development of PE. In the same manner, foetal well-being may also be compromised by SDB contributing to placental ischaemia. Habitual snoring in pregnancy has been associated with enhanced foetal erythropoiesis (Tauman et al., 2011) , and women with SDB show significantly increased placental markers of chronic hypoxia and uteroplacental underperfusion (Ravishankar et al., 2015) .
It is possible that the observed high prevalence of SDB identified after being diagnosed with HDP in our study is partly due to physiological changes accompanying HDP. PE is associated with marked fluid retention that affects the upper airway resulting in pharyngolaryngeal oedema (Bourjeily et al., 2011) . As a result, upper airway size is smaller in PE (Izci et al., 2003) . We also found that our GH/PE group had a significantly larger neck circumference than the controls despite almost identical BMI, suggesting that SDB may be exacerbated by the presence of PE-related upper airway oedema. This is partly supported by our novel finding that RDI was higher among hypertensive women during supine sleep. Within our cohort, however, we did not find any relationship between neck size and severity of SDB.
Our study along with others has confirmed that subclinical and undiagnosed mild SDB is extremely common among women with higher BMI, irrespective of whether they have HDP (Louis et al., 2012; Pien et al., 2014) . It is not feasible to offer treatment to over a third of all women with an increased BMI; therefore, future research needs to determine at what severity threshold SDB should be considered significant enough to intervene. In our study, all women with SDB were offered clinical review with a sleep physician, yet only three of these women attended and were commenced on continuous positive airway pressure. This has been identified in other studies (Facco et al., 2014b) , and suggests that women themselves regard this as relatively low priority and may not commit to what they perceive as onerous treatment. Better engagement may be more likely for women with more severe disease if stronger links with adverse pregnancy outcome are demonstrated.
The strengths of this study were that we used goldstandard full PSG to characterise SDB rather than questionnaire data alone, which tends to overestimate the likelihood of SDB (Antony et al., 2014; Wilson et al., 2013) . Aligning with many past studies (Izci et al., 2003; O'Brien et al., 2014; Reid et al., 2011) , habitual snoring was reported by a substantial proportion of normotensive pregnant women and significantly more GH/PE women. Witnessed apneas were also reported by a fifth of GH/PE women. These symptoms along with high BMI and hypertension meant that many women in our cohort were considered as high risk for SDB on the Berlin Questionnaire. Unfortunately, screening tools will significantly overestimate the presence of SDB within hypertensive and obese cohorts of pregnant women, which limits their utility in clinical practice.
The use of full PSG also enabled us to look at differences across sleep stages and body positions, and detect subtle changes in airflow as well as more discrete events. In particular, we found that SDB in NREM sleep and supine sleep was significantly more severe in HDP compared with normotensive women despite no difference in overall RDI. This is a strength in comparison to studies that have used abbreviated monitoring techniques (Facco et al., 2013 (Facco et al., , 2014a (Facco et al., , 2017 Louis et al., 2012; Yinon et al., 2006) . Abbreviated devices may underestimate SDB prevalence due to estimation of sleep time, and the absence of EEG monitoring means hypopneas with arousal will be undetected.
Our study utilised domiciliary PSGs as well as in-laboratory. This may be considered a limitation as unattended studies are prone to signal quality problems; however, we had a high success rate with only one failure from 58 home studies. Almost three-quarters of our sample chose to have their sleep study at home. Anecdotally, the pregnant women were not keen on spending an extra night in the hospital in an unfamiliar bed, particularly those who were receiving additional antenatal monitoring for clinical reasons. Our results may be useful for ª 2018 European Sleep Research Society future research in this area, demonstrating that women who have a home study may sleep better in terms of sleep efficiency, but measures of SDB are comparable.
A further limitation of our study is that we were underpowered for our primary outcome given the higher than expected prevalence of SDB in the control group. In order to have enough power to obtain a significant difference between frequency of SDB in HDP and BMI-matched controls in our study, we would have needed 169 participants per group. Nevertheless, this is important information to inform the sample size and power of future studies, particularly when matching for the important co-variate of BMI.
CONCLUSI ON
Sleep-disordered breathing occurs in half of women diagnosed with a gestational hypertensive disorder; however, it is also common in normotensive women of similar body habitus, with our results suggesting that the previously reported relationship between SDB and hypertension in pregnancy is due at least in part to the confounding effect of obesity. More severe SDB was at least twice as common in women with HDP, suggesting a multifactorial relationship with directionality still needing to be established. The high prevalence of this condition raises questions of a threshold of clinical significance, with further research required to determine at what severity the value of treatment should be tested.
